News
Bristol-Myers Squibb has been navigating some choppy waters but seems poised for a turnaround. Recently, shares have ticked ...
Bristol Myers Squibb appointed Nathan Pennell, MD, PhD, FASCO, as SVP, worldwide head of medical affairs for hematology and oncology, effective August 18. Nucleus RadioPharma hired former Food and ...
Bristol-Myers Squibb Company is pushing the boundaries with its latest clinical study on Deucravacitinib. The drug targets moderate to severe systemic lupus erythematosus (SLE). Employing a ...
Valuewalk on MSN1d
Three High Yield Stocks For Reliable Income
The average dividend yield in the S&P 500 Index remains low at around 1.3%. As a result, many stocks have lower dividend ...
3d
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...
All Penny Stocks (English) on MSN4d
The Next Wave of Cancer Innovation: How Breakthrough Therapies Are Redefining Treatment Paradigms
Personalized and targeted cancer therapies are showing unprecedented promise, with novel approaches potentially ...
Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback